Davenport & CO LLC Alnylam Pharmaceuticals, Inc. Transaction History

Davenport & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$127.18 - $173.91 $471,201 - $644,336	-3,705 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$159.56 - $209.29 $45,953 - $60,275	288 Added 8.43%	3,705 $628,000
Q3 2021 Oct 14, 2021	BUY	$169.75 - $207.73 $90,476 - $110,720	533 Added 18.48%	3,417 $645,000
Q2 2021 Jul 28, 2021	BUY	$128.63 - $176.89 $370,968 - $510,150	2,884 New	2,884 $489,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.